GTHX Market Cap History
Below is a table of the GTHX market cap history going back to 5/17/2017:

Date GTHX Market Cap
5/17/2017399.96M
7/31/2017402.50M
10/31/2017669.80M
2/16/2018560.08M
4/30/20181.25B
7/31/20181.72B
10/31/20181.49B
2/25/2019755.27M
4/30/2019801.80M
7/31/2019930.94M
12/31/20182.53B
10/31/2019797.48M
2/21/2020676.05M
4/30/2020495.49M
7/31/2020557.67M
10/30/2020418.12M
2/22/20211.08B
4/30/2021886.51M
7/30/2021733.05M
10/29/2021616.15M
2/21/2022409.12M
4/29/2022219.51M
7/29/2022356.08M
10/28/2022472.46M

Also see: GTHX Shares Outstanding History
and GTHX YTD Return
GTHX Historical Market Cap:
+3.10% CAGR
GTHX Historical Market Cap: +3.10% CAGR

Mouse over chart for data details
5/17/2017 ...10/28/2022
G1 Therapeutics is a commercial-stage biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer. Co.'s primary compound trilaciclib is a therapy designed to help protect against chemotherapy-induced myelosuppression. Trilaciclib helps protect hematopoietic stem and progenitor cells in the bone marrow by transiently inhibiting CDK4/6 leading to a temporary arrest of susceptible host cells during chemotherapy in patients. Rintodestrant is an oral selective estrogen receptor degrader for the treatment of ER+ breast cancer. We show 24 historical shares outstanding datapoints in our GTHX shares outstanding history coverage, used to compute GTHX market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing GTHX market cap history over the course of time is important for investors interested in comparing GTHX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of GTHX versus a peer is one thing; comparing GTHX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like GTHX can fluctuate over the course of history. With this page we aim to empower investors researching GTHX by allowing them to research the GTHX market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree GTHX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
G1 Therapeutics (GTHX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

GTS Market Cap History
GTXI Market Cap History
HAE Market Cap History
HAIR Market Cap History
HALO Market Cap History
HARP Market Cap History
HBIO Market Cap History
HCA Market Cap History
HCWB Market Cap History
HEPA Market Cap History
More Healthcare companies »

 

GTHX Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2023, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.